Does caffeine lead to psychological dependence?

CHEMTECH

Volumn 29, Issue 7, 1999, Pages 30-35

  Nehlig, Astrid ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0013249518     PISSN: 00092703     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Benowitz, N. L. Annu. Rev. Med. 1990, 41, 277-288.
2. Gilliland, K.; Bullock, W. Adv. Alcohol Subst. Abuse 1984, 3, 53-73.
3. Holtzman, S. G. Trends Pharmacol Sci. 1990, 11, 355-356.
4. Hughes, J. R.; Oliveto, A. H.; Helzer, J. E.; Higgins, S. T.; Bickel, W. K. Am. J. Psychiatry 1992, 149, 33-40.
5. Debry, G. Coffee and Health; John Libbey: Paris, 1994.
6. Barone, J. J.; Roberts, H. R. Food Chem. Toxicol. 1996, 34, 119-126.
7. Ellison, C. R.; Singer, M. R.; Moore, L. L.; Nguyen, U.S.D.T.; Garrahie, E.; Maror, J. K. J. Am. Diet. Assoc. 1995, 95, 802-804.
8. Sokoloff, L.; Reivich, M.; Kennedy, C.; Des Rosiers, M. H.; Patlak, C. S.; Pettigrew, K. D.; Sakurada, O.; Shinohara, M. J. Neurochem. 1977, 28, 897-916.
9. Nehlig, A.; Daval, J. L.; Debry, G. Brain Res. Rev. 1992, 17, 139-170.
10. Okada, M.; Kiryu, K.; Kawata, Y.; Mizuno, K.; Wada, K.; Tasaki, H.; Kaneko, S. Eur. J. Pharmacol. 1997, 321, 181-188.
11. Johansson, B.; Lindström, K.; Fredholm, B. B. Neurosci. 1994, 59, 837-849.
12. Heishman, S. J.; Henningfield, J. E. Neurosci. Biobehav. Rev. 1992, 16, 273-287.
13. World Health Organization. The ICD-10 Classification of Mental Behavioural Disorders, Clinical Descriptions and Diagnostic Guidelines; Geneva, Switzerland, 1992.
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed.; American Psychiatric Association: Washington, DC, 1994.
15. Nehlig, A. Neurosci. Biobehav. Rev. 1999, 23, 563-576.
16. Hughes, J. R.; Oliveto, A. H.; Helzer, J. E.; Bickel, W. K.; Higgins, S. T. Problems of Drug Dependence 1992; Harris, L. S., Ed.; National Institute on Drug Abuse (NIDA) Research Monograph No. 132; National Institutes of Health (NIH) Publication No. 93-3505; U.S. Government Printing Office: Washington, DC, 1993; p. 194.
17. Strain, E. C.; Mumford, G. K.; Silverman, K.; Griffiths, R. R. J. Am. Med. Assoc. 1994, 272, 1043-1048.
18. Nehlig, A.; Daval, J. L.; Boyet, S.; Vert, P. Eur. J. Pharmacol. 1986, 129, 93-103.
19. Self, D. W.; Nestler, E. J. Annu. Rev. Neurosci. 1995, 18, 463-495.
20. Heimer, L.; Zahm, D. S.; Churchill, L.; Kalivas, P. W.; Wohltmann, C. Neuroscience 1991, 41, 89-125.
21. Pontieri, F. E.; Tanda, G.; Di Chiara, G. Proc. Natl. Acad. Sci. USA 1995, 92, 12304-12308.
22. Pontieri, F. E.; Tanda, G.; Orzi, F.; Di Chiara, G. Nature 1996, 382, 255-257.
23. Tanda, G.; Loddo, P.; Frau, R.; Acquas F.; Di Chiara, G. Proceedings of the Sixth International Symposium on Adenosine and Adenine Nucleotides, Ferrara, Italy, 19-24 May 1998.
24. Fredholm, B. B. Pharmacol. Toxicol. 1995, 76, 93-101.
25. Ferré, S.; Fuxe, K.; von Euler, G.; Johansson, B.; Fredholm, B. B. Neuroscience 1992, 51, 501-512.
26. Phillips-Bute, B. G.; Lane, J. D. Physiol. Behav. 1998, 63, 35-39.
27. Rogers, P. J.; Dernoncourt, C. Pharmacol. Biochem. Behav. 1998, 59, 1039-1045.